Kim, Daehoon
Yang, Pil-Sung
Sung, Jung-Hoon
Jang, Eunsun
Yu, Hee Tae
Kim, Tae-Hoon
Uhm, Jae-Sun
Kim, Jong-Youn
Pak, Hui-Nam
Lee, Moon-Hyoung
Lip, Gregory Y. H.
Joung, Boyoung https://orcid.org/0000-0001-9036-7225
Funding for this research was provided by:
Korean Heart Rhythm Society
Ministry of Health and Welfare (HI15C1200, HC19C0130)
Article History
Received: 26 December 2020
Accepted: 17 February 2021
First Online: 17 March 2021
Ethics approval and consent to participate
: This study was approved by the Institutional Review Board of the Yonsei University Health System (4-2016-0179). The requirement for informed consent was waived because personal identification information was removed after cohort generation, in accordance with the strict confidentiality guidelines.
: All authors have permitted the publication.
: Dr. Gregory Y.H. Lip has served as a consultant for Bayer/Janssen, BMS/Pfizer, Biotronik, Medtronic, Boehringer Ingelheim, Novartis, Verseon, and Daiichi-Sankyo and as a speaker for Bayer, BMS/Pfizer, Medtronic, Boehringer Ingelheim, and Daiichi-Sankyo. Dr. Boyoung Joung has served as a speaker for Bayer, BMS/Pfizer, Medtronic, and Daiichi-Sankyo and received research funds from Medtronic and Abbott. Neither author has received any fees directly. The other authors have nothing to declare.